Original Article

You have full text access to this OnlineOpen article

IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study

  1. Yan Guo1,2,
  2. Li-Shu Zhang3,
  3. Tie-Lin Yang1,2,
  4. Qing Tian2,
  5. Dong-Hai Xiong2,
  6. Yu-Fang Pei1,2,
  7. Hong-Wen Deng1,2,3,4,*

Article first published online: 14 DEC 2009

DOI: 10.1359/jbmr.091040

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 5, pages 1042–1048, May 2010

Additional Information

How to Cite

Guo, Y., Zhang, L.-S., Yang, T.-L., Tian, Q., Xiong, D.-H., Pei, Y.-F. and Deng, H.-W. (2010), IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study. J Bone Miner Res, 25: 1042–1048. doi: 10.1359/jbmr.091040

Author Information

  1. 1

    Key Laboratory of Biomedical Information Engineering of Ministry of Education, and Institute of Molecular Genetics, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, People's Republic of China

  2. 2

    School of Medicine, University of Missouri–Kansas City, Kansas City, MO, USA

  3. 3

    College of Life Sciences and Engineering, Beijing Jiao Tong University, Beijing, People's Republic of China

  4. 4

    Center of Systematic Biomedical Research, Shanghai University of Science and Technology, Shanghai, People's Republic of China

*Key Laboratory of Biomedical Information Engineering of Ministry of Education and Institute of Molecular Genetics, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China.

Publication History

  1. Issue published online: 30 APR 2010
  2. Article first published online: 14 DEC 2009
  3. Accepted manuscript online: 27 JAN 2010 12:00AM EST
  4. Manuscript Accepted: 22 OCT 2009
  5. Manuscript Revised: 12 JUL 2009
  6. Manuscript Received: 27 MAR 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (120K)

References

  • 1
    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359: 1761–1767.
  • 2
    Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997; 12: 24–35.
    Direct Link:
  • 3
    Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 1185–1194.
    Direct Link:
  • 4
    Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 1033–1046.
  • 5
    Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008; 42: 467–475.
  • 6
    Arden NK, Baker J, Hogg C, Baan K, Spector TD. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res. 1996; 11: 530–534.
    Direct Link:
  • 7
    Videman T, Levalahti E, Battie MC, Simonen R, Vanninen E, Kaprio J. Heritability of BMD of femoral neck and lumbar spine: a multivariate twin study of Finnish men. J Bone Miner Res. 2007; 22: 1455–1462.
    Direct Link:
  • 8
    Guo Y, Yang TL, Pan F, Xu XH, Dong SS, Deng HW. Molecular genetic studies of gene identification for osteoporosis. Expert Rev. Endocrinol. Metab. 2008; 3: 223–267.
  • 9
    Ioannidis JP, Ralston SH, Bennett ST, et al. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004; 292: 2105–2114.
  • 10
    Ralston SH, Uitterlinden AG, Brandi ML, et al. Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med. 2006; 3: e90.
  • 11
    Uitterlinden AG, Ralston SH, Brandi ML, et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006; 145: 255–64.
  • 12
    van Meurs JB, Trikalinos TA, Ralston SH, et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 2008; 299: 1277–1290.
  • 13
    Richards JB, Rivadeneira F, Inouye M, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008; 371: 1505–1512.
  • 14
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358: 2355–2365.
  • 15
    Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet. 2007; 8: S14.
  • 16
    Riancho JA, Sanudo C, Valero C, et al. Association of the aromatase gene alleles with bone mineral density: epidemiological and functional evidence. J Bone Miner Res. 2009.
    Direct Link:
  • 17
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. New sequence variants associated with bone mineral density. Nat Genet. 2009; 41: 15–7.
  • 18
    Xiong DH, Liu XG, Guo YF, et al. Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet. 2009.
  • 19
    Deng HW, Mahaney MC, Williams JT, et al. Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol. 2002; 22: 12–25.
    Direct Link:
  • 20
    Cupples LA, Arruda HT, Benjamin EJ, et al. The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet. 2007; 8: S1.
  • 21
    Hannan MT, Felson DT, Anderson JJ. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res. 1992; 7: 547–53.
    Direct Link:
  • 22
    Liu YJ, Liu XG, Wang L, et al. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet. 2008; 17: 1803–1813.
  • 23
    Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics. 2006; 22: 7–12.
  • 24
    Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38: 904–909.
  • 25
    Lange C, DeMeo DL, Laird NM. Power and design considerations for a general class of family-based association tests: quantitative traits. Am J Hum Genet. 2002; 71: 1330–1341.
  • 26
    Rosenthal, Meta-Analytic Procedures For Social Research. Beverly Hills, CA: Sage; 1991.
  • 27
    Freimer N, Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet. 2004; 36: 1045–51.
  • 28
    Lencz T, Morgan TV, Athanasiou M, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry. 2007; 12: 572–580.
  • 29
    Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263–265.
  • 30
    Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007; 39: 906–913.
  • 31
    Dobnig H, Turner RT. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995; 136: 3632–3638.
  • 32
    Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999; 104: 439–446.
  • 33
    Zeggini E, Ioannidis JP. Meta-analysis in genome-wide association studies. Pharmacogenomics. 2009; 10: 191–201.
  • 34
    Hock JM, Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 1992; 7: 65–72.
    Direct Link:
  • 35
    Hock JM, Gera I, Fonseca J, Raisz LG. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology. 1988; 122: 2899–2904.
  • 36
    Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344: 1434–1441.
  • 37
    Deng HW, Li J, Li JL, Johnson M, Gong G, Recker RR. Association of VDR and estrogen receptor genotypes with bone mass in postmenopausal Caucasian women: different conclusions with different analyses and the implications. Osteoporos Int. 1999; 9: 499–507.
  • 38
    Gong G, Johnson ML, Barger-Lux MJ, Heaney RP. Association of bone dimensions with a parathyroid hormone gene polymorphism in women. Osteoporos Int. 1999; 9: 307–311.
  • 39
    Katsumata K, Nishizawa K, Unno A, Fujita Y, Tokita A. Association of gene polymorphisms and bone density in Japanese girls. J Bone Miner Metab. 2002; 20: 164–169.
  • 40
    Tenne M, McGuigan F, Jansson L, et al. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone. 2008; 42: 719–727.
  • 41
    Deng HW, Shen H, Xu FH, et al. Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res. 2002; 17: 678–686.
    Direct Link:
  • 42
    Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005; 308: 1149–1154.
  • 43
    Yamada K, Lim J, Dale JM, et al. Empirical analysis of transcriptional activity in the Arabidopsis genome. Science. 2003; 302: 842–846.
  • 44
    Hirschman JE, Durbin KJ, Winston F. Genetic evidence for promoter competition in Saccharomyces cerevisiae. Mol Cell Biol. 1988; 8: 4608–4615.
  • 45
    Martens JA, Wu PY, Winston F. Regulation of an intergenic transcript controls adjacent gene transcription in Saccharomyces cerevisiae. Genes Dev. 2005; 19: 2695–2704.
  • 46
    Xiao P, Chen Y, Jiang H, et al. In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. J Bone Miner Res. 2008; 23: 644–654.
    Direct Link:
  • 47
    Brandt K, Singh PB, Bulfone-Paus S, Ruckert R. Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev. 2007; 18: 223–232.
  • 48
    Jungel A, Distler JH, Kurowska-Stolarska M, et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum. 2004; 50: 1468–1476.
    Direct Link:
  • 49
    Lange EM, Sun J, Lange LA, et al. Family-based samples can play an important role in genetic association studies. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2208–2214.
View Full Article with Supporting Information (HTML) Get PDF (120K)